Evidence map›Paper›PMID 40725019›Full record

ArticleInternational journal of molecular sciences2025

Oxidative Stress and Psychiatric Symptoms in Wilson's Disease.

Grażyna Gromadzka, Agata Karpińska, Tomasz Krzysztof Szafrański, Tomasz Litwin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Grażyna GromadzkaDepartment of Biomedical Sciences, Faculty of Medicine, Collegium Medicum, Cardinal Stefan Wyszynski University, Woycickiego Street 1/3, 01-938 Warsaw, Poland.ORCID 0000-0002-4325-8971
Agata KarpińskaDepartment of Experimental and Clinical Pharmacology, Medical University of Warsaw, Banacha 1b Str., 02-097 Warsaw, Poland.
Tomasz Krzysztof SzafrańskiDepartment of Psychiatry, Faculty of Medicine, Lazarski University, Anna Gostyńska Wolski Hospital, Marcina Kasprzaka 17 Street, 01-211 Warsaw, Poland.ORCID 0000-0002-4181-3492
Tomasz LitwinDepartment of Neurology, Stroke Unit and Rehabilitation Subunit, Anna Gostynska Wolski Hospital, Marcina Kasprzaka 17 Street, 01-211 Warsaw, Poland.ORCID 0000-0003-2670-9651

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wilson's disease (WD) is an autosomal recessive disorder of copper metabolism caused by mutations in the

Indexed as

Hepatolenticular DegenerationOxidative StressAdolescentAdultCatalaseChildCopperFemaleGenotypeGlutathione PeroxidaseGlutathione Peroxidase GPX1HumansMaleMiddle AgedPolymorphism, Single NucleotideSuperoxide DismutaseCatalaseCopperGlutathione PeroxidaseGlutathione Peroxidase GPX1GPX1 protein, humanSuperoxide DismutaseSuperoxide Dismutase 28-iso-PGF2α8-OHdGCATcatalasecoppergenotypeglutathioneglutathione peroxidaseGPXmanganese superoxide dismutaseMnSODoxidative stresspolymorphismpsychiatric symptomsSOD2total antioxidant capacityWilson’s disease

Identifiers

PMID40725019
PMCPMC12295561

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.